Inhibition of miR-21 Induces Biological and Behavioral Alterations in Diffuse Large B-Cell Lymphoma

Publisher： Karger

E-ISSN： 1421-9662|130|2|87-94

ISSN： 0001-5792

Source： Acta Haematologica, Vol.130, Iss.2, 2013-03, pp. : 87-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R‐GEM‐P) is an effective regimen in relapsed diffuse large B‐cell lymphoma

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 219-226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deliverability and efficacy of R‐CHOP chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: an Australian retrospective analysis

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1147-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiplex polymerase chain reaction‐based prognostic models in diffuse large B‐cell lymphoma patients treated with R‐CHOP

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 174, Iss. 6, 2016-09 ,pp. : 876-886

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differential Therapy for Diffuse Large B-Cell Lymphoma with Different Cells of Origin

By  

Oncology Research and Treatment, Vol. 32, Iss. 12, 2009-11 ,pp. : 711-712

Karger

Access to resources Recommend Favorite

Primary diffuse large B‐cell lymphoma of the testis relapsing in the right atrium

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 4, 2015-02 ,pp. : 469-469

John Wiley & Sons Inc

Access to resources Recommend Favorite